Work

A phase III randomized controlled study comparing iron sucrose intravenously (IV) to no iron treatment of anemia in cancer patients undergoing chemotherapy and erythropoietin stimulating agent (ESA) therapy

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.9109

Authors: R. E. Bellet, H. Ghazal, M. Flam, A. Drelichman, N. Gabrail, D. Woytowitz, D. Loesch, D. Niforos, A. Mangione, L. Anthony, Iron Sucrose Study Group

Institution: Newland Medical Associates

Language: English

Topic: Erythropoietin and Anemia Treatment

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2328635004

Cites:

Cited by: 21

Related to: 10